Reading the tape
NYSE: INSP
Inspire Medical Systems, Inc.
Healthcare · Medical - Devices
Market Cap
$1.32B
52w High
$163.35
52w Low
$44.43
P/E
10.02
Volume
1.10M
Outstanding Shares
28.80M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
1Y Price: -65.45%Revenue (TTM): 8.94%FCF (TTM): 22.65%P/S: 0th pct
What changed
The stock fell 65.45% over the last year. Revenue grew 8.94% over the trailing twelve months. Operating margin moved from 5.93% to 5.61%. Free cash flow grew 22.65% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently 5.61%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
CEOTimothy Herbert
SectorHealthcare
IndustryMedical - Devices
Employees1,246
IPO dateMay 3, 2018
Valuation
Forward P/E—
EV/EBITDA40.61
Enterprise value$2.64B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth1.62%
Gross margin85.78%▲0.84%vs FY2024
Operating margin5.61%▲24.31%vs FY2024
ROE18.62%▲139.95%vs FY2024
Analyst consensus
RatingHold
Target price$86.83▲89.67%
13
Buy
14
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 3, 2026
Q3 FY26 · EPS est $0.20 · Revenue est $204.72M
View